Vatanidipine

CAS No. 116308-55-5

Vatanidipine( —— )

Catalog No. M34043 CAS No. 116308-55-5

Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 299 Get Quote
5MG 454 Get Quote
10MG 621 Get Quote
25MG 911 Get Quote
50MG 1224 Get Quote
100MG 1575 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Vatanidipine
  • Note
    Research use only, not for human use.
  • Brief Description
    Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.
  • Description
    Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.A slow-onset and long-lasting hypotensive action was observed in various experimental hypertensive models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    116308-55-5
  • Formula Weight
    686.8
  • Molecular Formula
    C41H42N4O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OCCC1=CC=C(C=C1)N2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)(=O)C=5C(C(C(OC)=O)=C(C)NC5C)C6=CC(N(=O)=O)=CC=C6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Fenoverine

    Fenoverine (Spasmopriv) is a novel smooth muscle motor synchronizer with anti-spasmodic activity that inhibits fast and slow Ca2+ channel currents in a concentration-dependent manner and can be used to study gastrointestinal spasms.

  • Nisoldipine

    A dihydropyridine type calcium channel blocker that is used as an antihypertensive.

  • Nexopamil

    Nexopamil (LU-49938) is a calcium channel antagonist and a 5-hydroxytryptamine 2A receptor antagonist.